This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) slipped 5.19% to $18.63 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 2.48% to 10,353.17 and Dow Jones Industrial Average falling 1.95% to 32,513.94. The stock's fall snapped a two-day winning streak. Novavax Inc. closed $217.87 short of its 52-week high ($236.50), which the company reached on December 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Replimune Group Inc. (REPL) fell 0.89% to $17.88, VBI Vaccines Inc. (VBIV) fell 6.57% to $0.61, and AnaptysBio Inc. (ANAB) fell 0.95% to $29.29. Trading volume (6.3 M) eclipsed its 50-day average volume of 5.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 9, 2022.
(END) Dow Jones Newswires
November 09, 2022 17:13 ET (22:13 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.